FUJI CHEMICAL INDUSTRIES CO LTD

Overview

FUJI CHEMICAL INDUSTRIES CO LTD is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering DRIED FERROUS SULFATE USP; FERROUS FUMARATE USP; IBUPROFEN USP; L-SELENOMETHIONINE USP; NIP-022TM; SELENIUM SULFIDE USP.

API / Drug Master Files

FUJI CHEMICAL INDUSTRIES CO LTD holds 7 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• L-SELENOMETHIONINE USPActive2026-03-04
• IBUPROFEN USPActive2022-03-16
• SELENIUM SULFIDE USPActive2021-07-10
• DRIED FERROUS SULFATE USPActive2015-03-25
• FERROUS FUMARATE USPActive2015-03-25
• NIP-022TMActive2009-03-26
• SUCRALFATEActive1979-06-12
• NTC-801FInactive2009-10-06
• PAROGRELILInactive2007-11-20
• MANUFACTURING, FACILITIES AND CONTROLS FOR GOHKAKIZAWA FACTORY IN TOYAMA, JAPANInactive1996-10-28
• ALPROSTADILInactive1996-02-06
• L-LYSINE 50% SOLUTIONInactive1992-02-25

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to FUJI CHEMICAL INDUSTRIES CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.